Narrative
Full Description
Project narrative
On December 21, 2016, financial close was reached on a deal in which a syndicate of 13 banks — including Bank of China — entered into a $1,000 million USD syndicated revolving credit facility agreement with Zoetis Inc., a U.S.-based animal health company headquartered in Parsippany, New Jersey, engaged in the discovery, development, manufacture, and commercialization of veterinary vaccines and medicines for livestock and companion animals. The maturity of the loan is five years; the interest rate is LIBOR plus an applicable margin (margin not disclosed). The proceeds were used by the borrower for general corporate purposes. Bank of China contributed to this loan (Record ID#110412). While Bank of China contributed to this loan, the following lenders also participated: JPMorgan Chase Bank, N.A., Bank of America, N.A., Barclays Bank PLC, Citibank, N.A., The Bank of Tokyo-Mitsubishi UFJ, Ltd., BNP Paribas, Coöperatieve Rabobank U.A., New York Branch, Goldman Sachs Bank USA, HSBC Bank USA, National Association, Standard Chartered Bank, TD Bank, N.A., and Wells Fargo Bank, National Association. On December 21, 2018, the parties agreed to extend the maturity of the loan by one year to December 21, 2023. Bank of China’s contribution is recorded in Record ID#110413. On December 21, 2022, financial close was reached on a deal in which a syndicate of 13 banks — including Bank of China — entered into a new five-year $1,000 million USD syndicated revolving credit facility agreement with Zoetis Inc. for general corporate purposes. While Bank of China contributed to this loan (Record ID#110414), the following lenders also participated: JPMorgan Chase Bank, N.A., Bank of America, N.A., Citibank, N.A., Barclays Bank PLC, MUFG Bank, Ltd., Banco Bilbao Vizcaya Argentaria S.A., BNP Paribas, Coöperatieve Rabobank U.A., New York Branch, Goldman Sachs Bank USA, HSBC Bank USA, National Association, Standard Chartered Bank, and TD Bank, N.A.
Staff comments
1. The entirety of the loan contract can be accessed at https://www.sec.gov/Archives/edgar/data/1555280/000155528022000287/zoetis-2022creditagreement.htm 2. Zoetis Inc. is an American animal health company headquartered in Parsippany, New Jersey. Formerly the animal health division of Pfizer, it became an independent company in 2013 and develops, manufactures, and commercializes veterinary vaccines and medicines. 3. AidData estimates the interest rate by adding the 6-month average LIBOR rate in December 2016 (approximately 1.27%) and an applicable margin based on the company’s credit rating at the time (BBB or 1.125%). 4. The individual contributions of the 13 lenders to this $1,000 million USD syndicated loan are unknown. For the time being, AidData has estimated the contribution of Bank of China by assuming that each lender contributed an equal amount ($76.92 million USD) to the loan syndicate.